Vasa previa screening strategies: decision and cost-effectiveness analysis

被引:30
作者
Sinkey, R. G. [1 ]
Odibo, A. O. [2 ]
机构
[1] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Maternal Fetal Med, Birmingham, AL 35294 USA
[2] Univ S Florida, Dept Obstet & Gynecol, Div Maternal Fetal Med, Tampa, FL USA
关键词
cost-effectiveness; decision analysis; pulsed color Doppler; transvaginal ultrasound; vasa previa; PRENATAL-DIAGNOSIS; MANAGEMENT; ULTRASOUND; PREVENTION; GESTATION; OUTCOMES;
D O I
10.1002/uog.19098
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective To perform a decision and cost-effectiveness analysis comparing four screening strategies for the antenatal diagnosis of vasa previa in singleton pregnancies. Methods A decision-analytic model was constructed comparing vasa previa screening strategies. Published probabilities and costs were applied to four transvaginal screening scenarios that were carried out at the time of mid-trimester ultrasound: no screening, ultrasound-indicated screening, screening only pregnancies conceived by in-vitro fertilization (IVF) and universal screening. Ultrasound-indicated screening was defined as performing transvaginal ultrasound at the time of the routine anatomy ultrasound scan in response to one of the following sonographic findings associated with an increased risk of vasa previa: low-lying placenta, marginal or velamentous cord insertion or bilobed or succenturiate lobed placenta. The primary outcome was cost per quality-adjusted life year (QALY) in US$. The analysis was performed from a healthcare system perspective with a willingness-to-pay threshold of $100000 per QALY selected. One-way and multivariate sensitivity analysis (Monte-Carlo simulation) was performed. Results This decision-analytic model demonstrated that screening pregnancies conceived by IVF was the most cost-effective strategy, with an incremental cost effectiveness ratio (ICER) of $29186.50/QALY. Ultrasound-indicated screening was the second most cost-effective, with an ICER of $.56096.771QALY. These data were robust to all one-way and multivariate sensitivity analyses performed. Conclusions Within the baseline assumptions, transvaginal ultrasound screening for vasa previa appears to be most cost-effective when performed among IVF pregnancies. However, both IVF and ultrasound-indicated screening strategies fall within contemporary willingness-to-pay thresholds, suggesting that both strategies may be appropriate to apply in clinical practice. Copyright (C) 2018 ISUOG. Published by John Wiley & Sons Ltd.
引用
收藏
页码:522 / 529
页数:8
相关论文
共 40 条
[1]  
[Anonymous], 2014, OBSTET GYNECOL, V123, P693
[2]  
[Anonymous], 2009, Obstet Gynecol, V113, P748, DOI 10.1097/AOG.0b013e31819e9ee2
[3]   Prenatal ultrasound diagnosis of vasa praevia and analysis of risk factors [J].
Baulies, S. ;
Maiz, N. ;
Munoz, A. ;
Torrents, M. ;
Echevarria, M. ;
Serra, B. .
PRENATAL DIAGNOSIS, 2007, 27 (07) :595-599
[4]   Red cell and platelet transfusions in neonates: a population-based study [J].
Bowen, Jennifer R. ;
Patterson, Jillian A. ;
Roberts, Christine L. ;
Isbister, James P. ;
Irving, David O. ;
Ford, Jane B. .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2015, 100 (05) :F411-F415
[5]   Vasa Previa Clinical Presentations, Outcomes, and Implications for Management [J].
Bronsteen, Richard ;
Whitten, Amy ;
Balasubramanian, Mamtha ;
Lee, Wesley ;
Lorenz, Robert ;
Redman, Mark ;
Goncalves, Luis ;
Seubert, David ;
Bauer, Sam ;
Comstock, Christine .
OBSTETRICS AND GYNECOLOGY, 2013, 122 (02) :352-357
[6]  
Cahill AG, 2010, AM J OBSTET GYNECOL, V202, pE1, DOI [10.1016/j.ajog.2009.12.004, 10.1016/j.ajog.2009.12.005]
[7]   Prenatal sonographic diagnosis findings and obstetric outcome of vasa previa: ultrasound in ten cases [J].
Catanzarite, V ;
Maida, C ;
Thomas, W ;
Mendoza, A ;
Stanco, L ;
Piacquadio, KM .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (02) :109-115
[8]   Prenatally Diagnosed Vasa Previa A Single-Institution Series of 96 Cases [J].
Catanzarite, Val ;
Cousins, Larry ;
Daneshmand, Sean ;
Schwendemann, Wade ;
Casele, Holly ;
Adamczak, Joanna ;
Tith, Tevy ;
Patel, Ami .
OBSTETRICS AND GYNECOLOGY, 2016, 128 (05) :1153-1161
[9]   The cost-effectiveness of targeted or universal screening for vasa praevia at 18-20 weeks of gestation in Ontario [J].
Cipriano, L. E. ;
Barth, W. H., Jr. ;
Zaric, G. S. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (09) :1108-1118
[10]  
Committee on Practice BulletinsObstetrics The American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P964